Pavao Mark H
Transaction: 04/09/2026
BUY
Change
+10,000
Price
$4.53
Filing
04/09/2026
Type
BUY
Coya Therapeutics, Inc.
COYA • Biotechnology
$4.76
▲ +0.21 (+4.62%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$111.66M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 8.5Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 13, 2026, 12:19 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$4.76
Change4.62%
Shares Out23.46M
Market Cap$111.66M
Enterprise Value$-43.07B
52W Range3.71 - 7.75
Beta0.60
P/E-0.02
P/S0.44
P/B0.00
P/FCF-0.01
EV/Sales-171.24
Price$4.76
Change4.62%
Shares Out23.46M
Market Cap$111.66M
Enterprise Value$-43.07B
52W Range3.71 - 7.75
Beta0.60
P/E-0.02
P/S0.44
P/B0.00
P/FCF-0.01
EV/Sales-171.24
EV/EBITDA6.10
EV/FCF3.15
Dividend Yield0.00%
Gross Margin99.66%
Oper. Margin-2.55%
Profit Margin-2.67%
Debt/Eq0.00
Current Ratio8.50
Quick Ratio8.50
Target$12.00
Target Upside152.10%
Target Median$12.00
Target Range12.00 - 12.00
Volume82.06K
Avg Volume190.37K
EPS Surprise0.07
Investment DNA
How strong this company looks for long-term investors
34
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
52/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 8.5Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 6 analyst votes · 2026-09-05
100/100
Bullish
Bullish
6
Hold
0
Bearish
0
Price Target
2026-08-13
Low
$12.00
Mean
$12.00
Median
$12.00
High
$12.00
Insider Transactions
Recent executive and insider activity
Pavao Mark H
Transaction: 04/01/2026
OTHER
Change
0
Price
Not reported
Filing
04/09/2026
Type
OTHER
Swaminathan Arun
Transaction: 01/22/2026
BUY
Change
+293,983
Price
$4.73
Filing
01/26/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Pavao Mark H | BUY | +10,000 | $4.53 | 04/09/2026 | 04/09/2026 |
| Pavao Mark H | OTHER | 0 | Not reported | 04/01/2026 | 04/09/2026 |
| Swaminathan Arun | BUY | +293,983 | $4.73 | 01/22/2026 | 01/26/2026 |
| Berman Howard | BUY | +15,257 | $4.73 | 01/22/2026 | 01/26/2026 |
| Grossman Fred | BUY | +140,041 | $4.73 | 01/22/2026 | 01/26/2026 |
| SNYDER DAVID S | BUY | +140,041 | $4.73 | 01/22/2026 | 01/26/2026 |
| Lee Ann | BUY | +10,000 | $5.65 | 01/02/2026 | 01/06/2026 |
| ROSS WILBUR L JR | BUY | +10,000 | $5.65 | 01/02/2026 | 01/06/2026 |
| Weinand Dieter | BUY | +10,000 | $5.65 | 01/02/2026 | 01/06/2026 |
| GOLDSTEIN DOV A MD | BUY | +10,000 | $5.65 | 01/02/2026 | 01/06/2026 |
| Villalobos Anabella | BUY | +10,000 | $5.65 | 01/02/2026 | 01/06/2026 |
| GOLDSTEIN DOV A MD | SELL | -17,557 | $1.09 | 08/18/2025 | 08/19/2025 |
| GOLDSTEIN DOV A MD | BUY | +17,557 | $1.09 | 08/18/2025 | 08/19/2025 |
| ROSS WILBUR L JR | BUY | +5,000 | $5.97 | 02/25/2025 | 02/25/2025 |
| Weinand Dieter | BUY | +5,000 | $5.97 | 02/25/2025 | 02/25/2025 |
| GOLDSTEIN DOV A MD | BUY | +5,000 | $5.97 | 02/25/2025 | 02/25/2025 |
| Villalobos Anabella | BUY | +5,000 | $5.97 | 02/25/2025 | 02/25/2025 |
| Lee Ann | BUY | +5,000 | $5.97 | 02/25/2025 | 02/25/2025 |
| Berman Howard | BUY | +150,602 | $6.07 | 01/09/2025 | 01/13/2025 |
| Grossman Fred | BUY | +140,562 | $6.07 | 01/09/2025 | 01/13/2025 |